CIRRHOSIS ADVANCED

Clinical trials for CIRRHOSIS ADVANCED explained in plain language.

Never miss a new study

Get alerted when new CIRRHOSIS ADVANCED trials appear

Sign up with your email to follow new studies for CIRRHOSIS ADVANCED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could a common cholesterol drug slow liver scarring?

Disease control Recruiting now

This study tests whether rosuvastatin, a cholesterol-lowering drug, can safely slow or stop liver scarring (cirrhosis) compared to a placebo. About 256 adults with compensated cirrhosis will take the drug or placebo for 2 years. The main goal is to measure changes in liver stiffn…

Matched conditions: CIRRHOSIS ADVANCED

Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

CIRRHOSIS ADVANCED

Get alerted when new CIRRHOSIS ADVANCED trials appear

Could a common cholesterol drug slow liver scarring?